Patents by Inventor Wei-Ting CHAO

Wei-Ting CHAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibody-drug conjugates and uses thereof
    Patent number: 11384150
    Abstract: An immunoconjugate, comprising an anti-EGFR antibody or a binding fragment thereof, and a kinase inhibitor.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: July 12, 2022
    Assignees: Development Center for Biotechnology, Tunghai University
    Inventors: Shih-Hsien Chuang, Wei-Ting Chao, Wei-Ting Sun, Hui-Jan Hsu, Wun-Huei Lin
  • ANTIBODY-DRUG CONJUGATES AND USES THEREOF
    Publication number: 20200190199
    Abstract: An immunoconjugate, comprising an anti-EGFR antibody or a binding fragment thereof, and a kinase inhibitor.
    Type: Application
    Filed: December 13, 2017
    Publication date: June 18, 2020
    Inventors: Shih-Hsien Chuang, Wei-Ting Chao, Wei-Ting Sun, Hui-Jan Hsu, Wun-Huei Lin
  • METHOD FOR ASSESSING SENSITIVITY OF A TARGET DRUG IN VITRO AND A BIOMARKER USED THEREOF
    Publication number: 20170269061
    Abstract: This present invention is to provide a method for assessing sensitivity of target drug in vitro and a biomarker used thereof. It is to identify sensitivity of a target drug by analyzing expression levels of CAV-1 and Her-2 in a tissues sample provided by a subject to achieve effect of personal and precise medical treatment.
    Type: Application
    Filed: March 21, 2016
    Publication date: September 21, 2017
    Inventors: Wei-Ting CHAO, King-Jen CHANG, Yuan-Chiang CHUNG
  • Biochip
    Patent number: D841186
    Type: Grant
    Filed: December 23, 2015
    Date of Patent: February 19, 2019
    Assignee: TUNGHAI UNIVERSITY
    Inventor: Wei-Ting Chao